陕西省药品监督管理局关于对陕西步长制药有限公司等药品生产企业药品GMP符合性检查结果的通告

Core Viewpoint - The announcement from the Shaanxi Provincial Drug Administration details the results of GMP compliance inspections for three pharmaceutical companies, indicating varying levels of compliance with regulatory standards [2] Group 1: Company Compliance Results - Shaanxi Buchang Pharmaceutical Co., Ltd. was found to be compliant with GMP requirements during inspections conducted from September 16 to September 19, 2025, covering tablet production lines [2] - Xi'an Boai Pharmaceutical Co., Ltd. was found to be non-compliant with GMP requirements during inspections conducted from October 13 to October 17, 2025, focusing on raw material production lines [2] - Shaanxi Fujie Pharmaceutical Co., Ltd. was found to be compliant with GMP requirements during inspections conducted from October 28 to November 1, 2025, covering multiple production lines for raw materials [2]